EMA publishes CHMP assessment report for Accofil (filgrastim)

EMA

The EMA has published a summary of the European public assessment report (EPAR) for Accofil. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Accofil.

For more details, go to: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003956/human_med_001798.jsp&mid=WC0b01ac058001d124

Michael Wonder

Posted by:

Michael Wonder

Posted in: